Newsletter | December 19, 2024

12.19.24 -- Biologics Best Of 2024

SPONSOR

We’re ready to help usher your next drug into market! 2025’s first Outsourced Pharma Capacity Update provides a unique, virtual experience and the details necessary to find a CDMO for your specific timeline, volume, and production needs. Join us the last week of January as we draw the curtains on the industry’s best and give you complimentary VIP access to the resources available to support your success. Learn more and register to save your seat!

BEST OF FROM THE EDITOR

1.

BIO Expels WuXi, Agrees With US Government

2.

Exclusive Interview: WuXi AppTec Responds To BIOSECURE Act

3.

Novo Holdings Acquires Catalent, Shakes Up Outsourcing World

4.

Is WuXi AppTec An Enemy Of The State?

5.

Novo Holdings Clarifies, But Competitors Circling Catalent

BEST OF GUEST COLUMNS

1.

What Does The Catalent Acquisition By Novo Holdings Mean For The Biopharma Industry?

2.

Trends In FDA FY2023 Inspection-Based Warning Letters

3.

FDA Issues Draft Guidance On Use-Related Risk Analysis (URRA)

4.

The 6 Types of Bio/Pharmaceutical Consultants

5.

Shocking! Biotech Facilities Don't Maintain Themselves

BEST OF INDUSTRY INSIGHTS

1.

4 Steps To Identifying The CDMO Proposal Worth Signing

2.

Optimal Formulation Development

3.

The Challenges Of Biopharmaceutical Quality

4.

The Bioanalytical Development Journey

5.

Inclusion Bodies: Mother Nature's Help Or Hindrance?

6.

ICH Q14 101: Applying AQbD To CMC For Regulatory Success

7.

Understanding FDA Calibration Requirements And Best Practices For Reducing Risks

8.

Microbial Expression System For Efficient Production Of Therapeutic Proteins

9.

Innovations In ADC Technologies

10.

Selecting The Right pDNA Supplier: 10 Key Factors To Consider

SPONSOR

2025 BioPlan's 22nd Annual Survey--Biopharmaceutical Manufacturing

For over 20 years, we continue to be the leader in providing the biopharma industry's most comprehensive benchmarking analysis. We invite you to participate in our 22nd Annual Survey in Biopharmaceutical Manufacturing! For all completed, qualified responses, we'll send an Amazon egift card, a copy of the summary results (mid-2025), and our 2025 Top Trends in Biomanufacturing White Paper.

BEST OF SOLUTIONS

1.

Sterile Fill/Finish Capabilities

2.

Capacity Update May 2024: Fill/Finish

3.

Accelerated mAb Development Program

4.

Drug Product Fill Finish And Formulation Solutions

5.

Capacity Update February 2024: Large Molecule

6.

Capacity Update February 2024: Large Molecule

7.

Capacity Update July 2024: Fill/Finish

8.

De-Risk Your Drug Development: CMC Manufacturing

9.

Process Development And Clinical Manufacturing

10.

Improving CLD Efficiency With An Innovative Platform

Connect With Outsourced Pharma: